2013
DOI: 10.1016/j.neures.2013.08.010
|View full text |Cite
|
Sign up to set email alerts
|

Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…Our data demonstrating increased numerical density of DISCimmunopositive white matter OLs in paranoid schizophrenia indicate that DISC might belong to the latter group. However, contradictory results have yet been obtained with regard to DISC1 transcript expression patterns in cerebral and extra-cerebral tissues in schizophrenia: reduced DISC1 immunoreactivities in the prefrontal cortex [58], in pinealocytes in the same brains as studied here (Bernstein et al [59] in preparation), and in lymphocytes, but elevated DISC1 transcript levels in hippocampal tissue of schizophrenia patients [59,60] as well as in blood mononuclear cells of schizophrenia patients with positive symptoms during acute psychosis [61] and chronic schizophrenia [61,62]. Interestingly, in the latter study, it was found that treatment with antipsychotics (which considerably reduced patients' positive symptoms) also decreased DISC1 expression.…”
Section: Discussionmentioning
confidence: 99%
“…Our data demonstrating increased numerical density of DISCimmunopositive white matter OLs in paranoid schizophrenia indicate that DISC might belong to the latter group. However, contradictory results have yet been obtained with regard to DISC1 transcript expression patterns in cerebral and extra-cerebral tissues in schizophrenia: reduced DISC1 immunoreactivities in the prefrontal cortex [58], in pinealocytes in the same brains as studied here (Bernstein et al [59] in preparation), and in lymphocytes, but elevated DISC1 transcript levels in hippocampal tissue of schizophrenia patients [59,60] as well as in blood mononuclear cells of schizophrenia patients with positive symptoms during acute psychosis [61] and chronic schizophrenia [61,62]. Interestingly, in the latter study, it was found that treatment with antipsychotics (which considerably reduced patients' positive symptoms) also decreased DISC1 expression.…”
Section: Discussionmentioning
confidence: 99%
“…Venous blood was collected and extracted for genomic DNA using a commercially available genomic DNA kit (Omega Bio-tek, Norcross, GA, USA). Six SNPs (rs1261085, rs1261084, rs8766, rs9960767, rs2958182, and rs12966547) of the TCF4 gene were detected based on their likely involvement in SCZ [2,18,19]. As previously described, genotyping was performed by SNPscan Genotyping Assays on an ABI 7900HT Fast Real-Time PCR System (Genesky Biotechnologies Inc., Shanghai, China) according to the manufacturer's instructions [20].…”
Section: Snp Selection and Genotypingmentioning
confidence: 99%
“…In contrast, ∼75 kDa DISC1 hippocampal protein expression was found to be increased in schizophrenic patients [15]. A recent study identified decreased 91 kDa DISC1 immunoreactivity in the dorsolateral prefrontal cortex (DLPFC) in schizophrenic patients [36], while studies of DISC1 mRNA expression in this region have found no differences between schizophrenic patients and controls [15], [37]. There are several possible explanations for the apparent discrepancies between these studies: schizophrenia-associated changes in gene expression might be isoform, tissue- and/or brain region- specific; and/or aetiological heterogeneity might have resulted in systematic between-study sample differences.…”
Section: Discussionmentioning
confidence: 95%